Autoantigenic specificities of liver mitochondrial membranes.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1713090)

Published in Clin Exp Immunol on January 01, 1972

Authors

D H DeHeer, R N Pinckard, M S Olson

Articles cited by this

An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol (1967) 12.04

Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26

Enzymatic properties of the inner and outer membranes of rat liver mitochondria. J Cell Biol (1968) 8.20

Characteristics of isolated and purified preparations of the outer and inner membranes of mitochondria. Ann N Y Acad Sci (1966) 3.64

Mitochondrial antibodies and subclinical liver disease. Q J Med (1970) 2.28

LIVER AUTOANTIBODIES IN THE RAT. Immunology (1963) 2.24

Antibodies against the mitochondrial fraction of liver after toxic liver damage in rats. Clin Exp Immunol (1966) 2.24

Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med (1967) 2.09

Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75

Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes. Br J Exp Pathol (1969) 1.22

Development of complement-fixing 19S, anti-heart mitochondria autoantibody, following myocardial infarction in dogs. Circ Res (1971) 1.10

Antitissue antibodies and immunological tolerance to self. Arthritis Rheum (1969) 1.07

Failure to induce tolerance to rat tissue antigens. Immunology (1967) 1.07

Development of anti-tissue antibodies in rats. Clin Exp Immunol (1969) 1.00

A convenient spectrophotometric assay for monoamine oxidase. Anal Biochem (1969) 0.88

Altered antigens and autoimmunity. Vox Sang (1969) 0.82

Articles by these authors

Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem (1979) 4.31

Asymmetrical crossing barriers in angiosperms. Proc Biol Sci (2001) 2.37

Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31

Antibodies against the mitochondrial fraction of liver after toxic liver damage in rats. Clin Exp Immunol (1966) 2.24

Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). J Immunol (1981) 2.19

Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Lab Invest (1982) 2.14

Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12

Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.85

Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol (1977) 1.82

Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. J Immunol (1980) 1.77

Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol (1977) 1.76

Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75

Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J Clin Invest (1969) 1.75

Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem (1980) 1.61

A survey of physicians' attitudes and practices related to exercise promotion. Prev Med (1992) 1.61

Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest (1975) 1.59

Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit. Am Rev Respir Dis (1980) 1.54

In vitro acetylation of plasma proteins, enzymes and DNA by aspirin. Nature (1968) 1.51

Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem (2000) 1.48

Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46

Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest (1981) 1.42

Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation (1988) 1.39

Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. Circ Res (1984) 1.36

Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest (1984) 1.34

Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncol Nurs Forum (1997) 1.32

Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J Immunol (1973) 1.29

The regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1978) 1.28

Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab Invest (1982) 1.26

Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest (1980) 1.24

In vitro activation of complement by isolated human heart subcellular membranes. J Immunol (1979) 1.24

Studies of the effects of beta-adrenergic agonists on the regulation of pyruvate dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.22

Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. J Biol Chem (1984) 1.21

Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. J Biol Chem (1983) 1.21

Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. Am J Physiol (1981) 1.21

Platelet-activating factor. Hosp Pract (Off Ed) (1983) 1.16

Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem (1986) 1.16

Delineation of spontaneous erythrocyte autoantibody responses of NZB and other strains of mice. J Immunol (1978) 1.15

Endothelin, a potent peptide agonist in the liver. J Biol Chem (1990) 1.14

Acetylation of human serum albumin by acetylsalicylic acid. Science (1968) 1.13

End-of-life decision making by adolescents, parents, and healthcare providers in pediatric oncology: research to evidence-based practice guidelines. Cancer Nurs (2001) 1.12

Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol (2001) 1.11

Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol (1999) 1.11

Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit. Am Rev Respir Dis (1981) 1.10

Development of complement-fixing 19S, anti-heart mitochondria autoantibody, following myocardial infarction in dogs. Circ Res (1971) 1.10

The analysis of acyl-coenzyme A derivatives by reverse-phase high-performance liquid chromatography. Anal Biochem (1983) 1.10

The effect of fatty acids on the regulation of pyruvate dehydrogenase in perfused rat liver. Eur J Biochem (1978) 1.08

PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med (2000) 1.08

Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim Biophys Acta (1980) 1.08

Failure to induce tolerance to rat tissue antigens. Immunology (1967) 1.07

Basophil-derived platelet-activating factor (PAF) as an in vivo mediator of acute allergic reactions: demonstration of specific desensitization of platelets to PAF during IgE-induced anaphylaxis in the rabbit. J Immunol (1977) 1.07

Role of pyruvate transporter in the regulation of the pyruvate dehydrogenase multienzyme complex in perfused rat liver. Biochemistry (1982) 1.06

Specificity of antierythrocyte autoantibodies secreted by a NZB-derived hybridoma and NZB peritoneal cells. Cell Immunol (1980) 1.06

Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice. J Immunol (1976) 1.05

Regulation of the pyruvate dehydrogenase multienzyme complex. Annu Rev Nutr (1993) 1.05

Factors influencing the immune response. II. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intraperitoneal injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.05

Studies on the regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1979) 1.04

Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. Lab Invest (1981) 1.04

Regulation of pyruvate dehydrogenase by fatty acid in isolated rat liver mitochondria. J Biol Chem (1976) 1.04

Studies on the relationship between ketogenesis and pyruvate oxidation in isolated rat liver mitochondria. J Biol Chem (1978) 1.04

Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem (1998) 1.04

The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes. J Biol Chem (1984) 1.04

Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology (1997) 1.04

In vivo suppression of the primary immune response by a species of low density serum lipoprotein. J Immunol (1977) 1.03

Studies on the activation and inactivation of the branched chain alpha-keto acid dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.03

Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am J Physiol (1984) 1.03

Evidence for the regulation of the branched chain alpha-keto acid dehydrogenase multienzyme complex by a phosphorylation/dephosphorylation mechanism. Biochemistry (1982) 1.02

A quantitative genetic analysis of nuclear-cytoplasmic male sterility in structured populations of Silene vulgaris. Genetics (2001) 1.02

Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 1.01

Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver. Biochem J (1986) 1.01

Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs. Chem Phys Lipids (1984) 1.00

Regulation of the branched chain alpha-keto acid and pyruvate dehydrogenases in the perfused rat heart. J Biol Chem (1982) 0.99

Cardiovascular and metabolic costs of forward, backward, and lateral motion. Med Sci Sports Exerc (1998) 0.99

Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. Am J Pathol (1992) 0.98

The regulation of the pyruvate dehydrogenase complex in the perfused rat liver: a role for the mitochondrial monocarboxylate translocator. Arch Biochem Biophys (1982) 0.98

Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. Am J Pathol (1993) 0.97

The "new" chemical mediators of inflammation. Monogr Pathol (1982) 0.97

Electrospray ionization for analysis of platelet-activating factor. Rapid Commun Mass Spectrom (1991) 0.97

Stimulation of glycogenolysis and vasoconstriction by adenosine and adenosine analogues in the perfused rat liver. Biochem J (1987) 0.97

Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells. Endocrinology (1996) 0.96

Platelet activating factor (PAF) induced release of platelet factor 4 (PF4) in vitro and during IgE anaphylaxis in the rabbit. J Immunol (1979) 0.96

Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors. Cancer Res (1979) 0.96

Carpal bone titanium implant arthroplasty. 10 years' experience. Clin Orthop Relat Res (1997) 0.96

Control of citrate formation in rat liver mitochondria. Biochem Biophys Res Commun (1967) 0.95

Modification of the polar head group of acetyl glyceryl ether phosphorylcholine and subsequent effects upon platelet activation. J Biol Chem (1981) 0.95

A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J (1992) 0.95

The effects of alpha-adrenergic agonists on the regulation of the branched chain alpha-ketoacid oxidation in the perfused rat liver. J Biol Chem (1982) 0.95

Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver. Biochem J (1987) 0.94

Regulation of the glycine cleavage system in isolated rat liver mitochondria. J Biol Chem (1983) 0.94

Stimulation of glycogenolysis and platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver. J Biol Chem (1984) 0.94

Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology (1995) 0.93

PAF molecular heterogeneity: pathobiological implications. Lab Invest (1993) 0.93

Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619. J Biol Chem (1987) 0.93

Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes. Monogr Allergy (1977) 0.92

Two distinct pathways of platelet-activating factor-induced hydrolysis of phosphoinositides in primary cultures of rat Kupffer cells. J Biol Chem (1990) 0.92